Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry

NCT05880680 is registered in ClinicalTrials.gov with Galaxy Therapeutics INC as lead sponsor.

NCT NCT05880680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05880680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry
Lead sponsor
Galaxy Therapeutics INC
Phase
Observational
Overall status
Recruiting
Start date
October 9, 2023
Completion date
June 15, 2030
Enrollment
200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysm, aneurysm, ruptured